8 patents
Utility
Heterodimers of Glutamic Acid
30 Mar 23
John W. Babich, Craig N. Zimmerman, Kevin P. Maresca
Filed: 7 Nov 22
Utility
Preparations of Meta-iodobenzylguanidine and Precursors Thereof
12 Jan 23
Jason Moss, Machinani Rao
Filed: 14 Feb 22
Utility
Triazine Based Radiopharmaceuticals and Radioimaging Agents
4 Nov 21
John W. Babich, Craig Zimmerman, John L. Joyal, Genliang Lu
Filed: 21 Dec 20
Utility
Heterodimers of Glutamic Acid
12 Aug 21
John W. Babich, Craig N. Zimmerman, Kevin P. Maresca
Filed: 23 Apr 21
Utility
Heterodimers of Glutamic Acid
11 Mar 21
John W. Babich, Craig N. Zimmerman, Kevin P. Maresca
Filed: 8 May 20
Utility
Heterodimers of Glutamic Acid
11 Mar 21
John W. Babich, Craig N. Zimmerman, Kevin P. Maresca
Filed: 16 Nov 20
Utility
Organ Protection In Psma-targeted Radionuclide Therapy of Prostate Cancer
12 Aug 20
A method of reducing radiation exposure of a non-cancerous tissue of a patient diagnosed with a cancer includes administering to the patient an agent capable of competing for binding sites on a surface of the non-cancerous tissue, provided that the administration is carried out after a waiting period that follows administration of a compound including a radionuclide to the patient, the compound having affinity for both a cancerous tissue and the non-cancerous tissue, and, further provided that the binding sites have an affinity for both the agent and the compound.
John W. Babich, Shawn Hillier, John Joyal
Filed: 27 Apr 20
Utility
Preparations of Meta-iodobenzylguanidine and Precursors Thereof
4 Dec 19
Jason Moss, Machinani Rao
Filed: 10 Jun 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first